High Frequency of Rifampin Resistance Identified in an Epidemic Clostridium difficile Clone from a Large Teaching Hospital

BACKGROUND: Rifampin is used as adjunctive therapy for Clostridium difficile–associated disease, and the drug’s derivative, rifaximin, has emerged as an attractive antimicrobial for treatment of C. difficile–associated disease. Rifampin resistance in C. difficile strains has been reported to be unco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Curry, Scott R., Marsh, Jane W., Shutt, Kathleen A., Muto, Carlene A., O’Leary, Mary M., Saul, Melissa I., Pasculle, A. William, Harrison, Lee H.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819169/
https://ncbi.nlm.nih.gov/pubmed/19140738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/596315
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares